美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Renaissance International IPO ETF

22.20

-0.2902-1.29%

盤後：22.18-0.0248-0.11%16:10 EDT

成交量：1,125

成交額：2.50萬

市值：1,110.24萬

市盈率：- -

高：22.25

開：22.25

低：22.18

收：22.50

52周最高：26.25

52周最低：15.65

股本：50.00萬

流通股本：50.00萬

量比：0.57

換手率：0.22%

股息：0.14

股息率：0.65%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

上市險企「力推」派息險：掛鈎資負聯動，規模大增、新單佔比最高超九成

毛利率88%卻三年虧掉13億元，幾乎全部收入來自同一產品同一客户，思朗科技上市仍需邁過幾道坎

鑫巨宏IPO狀態變更為提交註冊

焦炭期權正式掛牌上市煤焦鋼產業鏈再添避險新工具

創金合信北京國資公司REIT：9月3日起在深交所上市交易

長城迎來久違大爆款！全新方盒子H10上市首月交付破萬

快科技官方

*ST康佳A：主動終止上市事項待審議股票即將停牌

華納藥廠(688799.SH)子公司化學原料藥艾拉莫德獲批上市

華納藥廠：子公司艾拉莫德原料藥獲上市申請批准

恒瑞醫藥(600276.SH)子公司HRS-7535片上市許可申請獲受理

恒瑞醫藥：HRS-7535片藥品上市許可申請獲受理

新股消息 | FundPark：正計劃進行C輪融資有考慮上市但未有時間表

翰森製藥(03692.HK)：注射用HS-20093治療小細胞肺癌上市許可申請獲國家藥品監督管理局受理

翰森製藥(03692)：注射用HS-20093治療小細胞肺癌上市許可申請獲國家藥品監督管理局受理

瑞星股份被證監局責令定期報告 2023上市華西證券保薦

破發股翱捷科技跌3.18% 2022上市超募42億國泰海通保薦

從上市初期陣痛到業績反轉突圍，瑞晟智能的增長底層邏輯是什麼？

唯捷創芯跌5.24% 2022年上市募資26.7億中信建投保薦

吉華集團跌7.7% 2017年上市募資17.2億國投證券保薦

*ST卓然連虧1年半 A股共募13億IPO國投證券保薦

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/IPOS/news?page=53"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IPOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPOS\",,,,,undefined,":{"symbol":"IPOS","market":"US","secType":"STK","nameCN":"Renaissance International IPO ETF","latestPrice":22.2048,"timestamp":1789502400000,"preClose":22.495,"halted":0,"volume":1125,"hourTrading":{"tag":"盘后","latestPrice":22.18,"preClose":22.2048,"latestTime":"16:10 EDT","volume":6,"amount":133.2288,"timestamp":1789503007320,"change":-0.0248,"changeRate":-0.001117,"amplitude":0},"delay":0,"changeRate":-0.012900644587686251,"floatShares":500001,"shares":500001,"eps":0,"marketStatus":"已收盤","change":-0.2902,"latestTime":"09-15 16:00:00 EDT","open":22.25,"high":22.25,"low":22.18,"amount":24999,"amplitude":0.003112,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":22.495,"sharesOutstanding":400001,"nav":22.516307,"aum":11258175.95,"dividendRate":0.006485,"bidAskSpread":0.004932,"postHourTrading":{"tag":"盘后","latestPrice":22.18,"preClose":22.2048,"latestTime":"16:10 EDT","volume":6,"amount":133.2288,"timestamp":1789503007320,"change":-0.0248,"changeRate":-0.001117,"amplitude":0},"volumeRatio":0.565554,"impliedVol":0.9594,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPOS\",,,,,undefined,":{"symbol":"IPOS","floatShares":500001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.565554,"shares":500001,"dividePrice":0.144,"high":22.25,"amplitude":0.003112,"preClose":22.495,"low":22.18,"week52Low":15.65,"pbRate":"--","week52High":26.25,"institutionHeld":0,"latestPrice":22.2048,"eps":0,"divideRate":0.006485,"volume":1125,"delay":0,"ttmEps":0,"open":22.25,"prevYearClose":16.8936,"prevWeekClose":22.665,"prevMonthClose":23.3188,"prevQuarterClose":25.635,"fiveDayClose":23.3527,"twentyDayClose":23.895,"sixtyDayClose":25.6848},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPOS\",params:#limit:5,,,undefined,":[{"date":"2026-09-11","symbol":"IPOS","amount":0.072205,"announcedDate":"2026-09-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-11","defaultRemindTime":1789133400000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-11","currency":"USD","dateTimestamp":1789099200000,"payDate":"2026-09-18"},{"date":"2026-06-12","symbol":"IPOS","amount":0.054103,"announcedDate":"2026-06-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-12","defaultRemindTime":1781271000000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-22","payableDate":"2026-06-12","currency":"USD","dateTimestamp":1781236800000,"payDate":"2026-06-22"},{"date":"2025-12-12","symbol":"IPOS","amount":0.017941,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-19"},{"date":"2025-09-12","symbol":"IPOS","amount":0.007352,"announcedDate":"2025-09-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-12","defaultRemindTime":1757683800000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-12","currency":"USD","dateTimestamp":1757649600000,"payDate":"2025-09-19"},{"date":"2025-06-13","symbol":"IPOS","amount":0.13555,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-13","defaultRemindTime":1749821400000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-13","currency":"USD","dateTimestamp":1749787200000,"payDate":"2025-06-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPOS\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.10823,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.15245,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-22","value":0.05857,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-23","value":0.00775,"currency":"USD"},{"executeDate":"2018-06-15","recordDate":"2018-06-18","paymentDate":"2018-06-22","value":0.2024,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IPOS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IPOS\",pageSize:20,pageCount:53,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664881891","title":"上市險企「力推」派息險：掛鈎資負聯動，規模大增、新單佔比最高超九成","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881891","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881891?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 17:34","pubTimestamp":1788341640,"startTime":"0","endTime":"0","summary":"蓝鲸新闻9月2日讯近日，A股上市险企半年报相继披露，分红险成为产品端最亮眼的存在：保费规模全线提速，新业务中分红险占比最高已超九成。不乏中小险企表示，正在严控分红险的增长速度与业务占比。资本实力较强的上市险企更具转型底气，上半年新业务中分红险占比进一步抬升。同期，新华保险长险新单中，分红型业务占比亦超过90%。更高维度，上市险企将分红险视为优化资产负债管理的关键落子。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/insurance/bxdt/2026-09-02/doc-iniqmshw2835776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664890967","title":"毛利率88%卻三年虧掉13億元，幾乎全部收入來自同一產品同一客户，思朗科技上市仍需邁過幾道坎","url":"https://stock-news.laohu8.com/highlight/detail?id=2664890967","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664890967?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 17:26","pubTimestamp":1788341200,"startTime":"0","endTime":"0","summary":"88%的毛利率，为何三年亏掉13亿元？更引人注目的是其毛利率表现，2025年高达88.59%，远超同行业58.77%的平均水平。到了2026年第一季度末，这一数字进一步攀升至7.95亿元。98%收入来自同一客户，存货周转率下滑至0.14思朗科技由中科院自动化所原所长王东琳创办。截至本招股说明书签署日，王东琳通过直接持股及其控制的平台合计控制公司33.67%的表决权，系思朗科技的控股股东、实控人。不过，思朗科技已经意识到了这一问题。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788340650191061697","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818851","title":"鑫巨宏IPO狀態變更為提交註冊","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818851","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818851?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 17:20","pubTimestamp":1788340800,"startTime":"0","endTime":"0","summary":"根据北交所最新披露的信息，2026年9月2日，无锡鑫巨宏智能科技股份有限公司IPO的状态从通过变更为提交注册。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2026-09-02/doc-iniqmshw2828823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["REDS","KCE","IPOS","FRHC","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664890316","title":"焦炭期權正式掛牌上市 煤焦鋼產業鏈再添避險新工具","url":"https://stock-news.laohu8.com/highlight/detail?id=2664890316","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664890316?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 17:19","pubTimestamp":1788340740,"startTime":"0","endTime":"0","summary":"模拟交易客户端9月2日，焦炭期权在大连商品交易所正式挂牌交易，标志着我国煤焦钢产业链衍生品工具体系进一步完善，为上下游产业主体新增精细化、多元化风险管理工具。随着焦炭期权正式挂牌交易，大商所已实现焦煤、焦炭、铁矿石三大黑色核心品种“期货+期权”双工具全覆盖，构建起完善的煤焦钢全链条衍生品风险管理矩阵，进一步提升煤焦钢产业链价格发现效率与风险对冲精准度。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/future/2026-09-02/doc-iniqmshw2827515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4535","PICK","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664393890","title":"創金合信北京國資公司REIT：9月3日起在深交所上市交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2664393890","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664393890?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 17:18","pubTimestamp":1788340701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS","RJMG","IQRA","PSCF","RNTY","YLDW","BPRE","IVRA","MDIV","DFRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819427","title":"長城迎來久違大爆款！全新方盒子H10上市首月交付破萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819427","media":"快科技官方","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819427?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 17:16","pubTimestamp":1788340605,"startTime":"0","endTime":"0","summary":"快科技9月2日消息，长城汽车官宣，旗下方盒子新能源SUV车型H10上市首月交付破万，达到10178台，凭借此成绩，H10成为长城整个集团久违的单一大爆款车型。H10是长城汽车首款以长城母品牌命名的“方盒子新物种”，为长城归元高端新能源平台的首款量产车型，提供五座和六座两种，前者长宽高5138*2050*1970mm，后者为5299*2050*1970mm，轴距统一为3000mm。","market":"sh","thumbnail":"https://k.sinaimg.cn/n/spider20260902/99/w600h1099/20260902/fd53-9c681f9d3667ad5c5883b8bd8fe4fc6d.jpg/w120h90l50t1376.jpg","type":0,"news_type":0,"thumbnails":["https://k.sinaimg.cn/n/spider20260902/99/w600h1099/20260902/fd53-9c681f9d3667ad5c5883b8bd8fe4fc6d.jpg/w120h90l50t1376.jpg"],"rights":{"source":"sina_tech","url":"https://tech.sina.cn/mobile/xp/2026-09-02/detail-iniqmshw7654361.d.html?vt=4","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}.weibo_user{#sourceStyle#; margin-bottom: 0; display: inline-block;}.weibo_time{#sourceStyle#};","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .j_float_wbro, .j_article_wbreco","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.sina.cn/mobile/xp/2026-09-02/detail-iniqmshw7654361.d.html?vt=4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_tech","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664972208","title":"*ST康佳A：主動終止上市事項待審議 股票即將停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2664972208","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664972208?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 17:09","pubTimestamp":1788340194,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897280","title":"華納藥廠(688799.SH)子公司化學原料藥艾拉莫德獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897280","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897280?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 17:00","pubTimestamp":1788339652,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华纳药厂(688799.SH)发布公告，近日，公司全资子公司湖南华纳大药厂手性药物有限公司(简称“手性药物”)收到国家药品监督管理局签发的艾拉莫德《化学原料药上市申请批准通知书》(通知书编号：2026YS00837)，并在国家药品监督管理局药品审评中心(CDE)“原辅包登记信息”平台公示。艾拉莫德是艾拉莫德片的原料药。艾拉莫德片主要用于治疗活动性类风湿关节炎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490941.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688799","BK0239","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897901","title":"華納藥廠：子公司艾拉莫德原料藥獲上市申請批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897901","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897901?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:58","pubTimestamp":1788339520,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897609","title":"恒瑞醫藥(600276.SH)子公司HRS-7535片上市許可申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897609","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897609?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:47","pubTimestamp":1788338861,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药(600276.SH)发布公告，近日，公司子公司山东盛迪医药有限公司收到国家药品监督管理局下发的《受理通知书》，公司HRS-7535片的药品上市许可申请获国家药监局受理。拟定适应症(或功能主治)：用于成人2型糖尿病患者的血糖控制。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1064130708.USD","BK0028","LU1328615791.USD","BK0183","LU1997244956.HKD","LU0359201885.HKD","LU0405327494.USD","LU2328871848.SGD","LU0359202008.SGD","LU0359201612.USD","LU1255011170.USD","LU2289578879.USD","01276","IPOS","LU2495084118.USD","BK0012","BK0239","LU1580142542.USD","LU2488822045.USD","LU2097828805.USD","LU2580892789.USD","LU1064131003.USD","LU2097828474.EUR","LU2148510915.USD","LU2543165471.USD","BK0060","LU1146622755.USD","BK0188","LU2097828714.EUR","LU0405327148.USD","LU1997245094.SGD","600276","LU2580892862.HKD","LU1820825898.SGD","LU2097828557.USD","LU2097828631.EUR","LU1023057109.AUD","LU1781817850.SGD","LU1969619763.USD","LU1997245177.USD","BK1191","LU1655091616.SGD","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897356","title":"恒瑞醫藥：HRS-7535片藥品上市許可申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897356","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897356?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:40","pubTimestamp":1788338423,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664689767","title":"新股消息 | FundPark：正計劃進行C輪融資 有考慮上市 但未有時間表","url":"https://stock-news.laohu8.com/highlight/detail?id=2664689767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664689767?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:35","pubTimestamp":1788338145,"startTime":"0","endTime":"0","summary":"另外，FundPark 联合创办人及中国区总裁莫招杰称，该公司较早前已完成B轮融资，正计划进行C轮融资。他又称，随着公司业务进一步发展，确有考虑上市计划，但现时未有时间表。孙慧来称，FundPark已支持逾4万家中小企，通过 AI 驱动的动态融资、前瞻性洞察以及增长支援服务，协助企业应对跨境贸易挑战，累计支用贷款总额超过90亿美元。他表示，FundPark 现时有逾200名员工、当中约100人在深圳办公室，主要从事技术层面的工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490912.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664892083","title":"翰森製藥(03692.HK)：注射用HS-20093治療小細胞肺癌上市許可申請獲國家藥品監督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664892083","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664892083?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:32","pubTimestamp":1788337920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664067892","title":"翰森製藥(03692)：注射用HS-20093治療小細胞肺癌上市許可申請獲國家藥品監督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664067892","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664067892?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:32","pubTimestamp":1788337920,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药(03692)发布公告，于2026年9月2日，集团创新药注射用HS-20093上市许可申请获中国国家药品监督管理局(NMPA)受理，用于治疗既往含铂治疗失败的小细胞肺癌(SCLC)成人患者。注射用HS-20093是一款集团自主研发的B7-H3靶向抗体-药物偶联物(ADC)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490907.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1191","IPOS","03692","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897844","title":"瑞星股份被證監局責令定期報告 2023上市華西證券保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897844","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897844?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:28","pubTimestamp":1788337682,"startTime":"0","endTime":"0","summary":"中国经济网北京9月2日讯 中国证监会网站昨日发布河北证监局关于对河北瑞星燃气设备股份有限公司及谷红军、谷红民、孙铁军、王俊生采取责令定期报告行政监管措施的决定。2026年一季度未召开审计委员会会议。　　瑞星股份2023年7月3日在北交所上市，发行数量为28,680,000股；32,982,000股，发行价格为5.07元/股，保荐人、承销商为华西证券股份有限公司，签字保荐代表人为周曼、廖高迁。　　瑞星股份发行费用总额为24,972,679.32元；26,805,626.37元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260902/32357807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002926","BK0276","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897304","title":"破發股翱捷科技跌3.18% 2022上市超募42億國泰海通保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897304","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897304?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:19","pubTimestamp":1788337141,"startTime":"0","endTime":"0","summary":"中国经济网北京9月2日讯 翱捷科技 今日收报94.69元，跌幅3.18%。该股目前处于破发状态。　　翱捷科技于2022年1月14日在上交所科创板上市，发行的股票数量为4183.0089万股，发行价格为164.54元/股，保荐人为海通证券股份有限公司，保荐代表人为王鹏程、龚思琪。翱捷科技最终募集资金净额比原计划多41.66亿元。　　翱捷科技首次公开发行股票的发行费用总额为3.37亿元，其中，保荐及承销费用3.10亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260902/32357797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0012","BK1147","BK0184","91545","02611","BK0276","BK1564","BK0028","BK0183","IPOS","BK0188","BK0201","601211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664921828","title":"從上市初期陣痛到業績反轉突圍，瑞晟智能的增長底層邏輯是什麼？","url":"https://stock-news.laohu8.com/highlight/detail?id=2664921828","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664921828?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:10","pubTimestamp":1788336602,"startTime":"0","endTime":"0","summary":"A股上市公司2026上半年业绩已披露完成。细究原因，并非是瑞晟智能的经营出现重大漏洞，疫情、研发加大、诉讼赔款等是主要原因。此外，因疫情管控需要，人员流动受到限制，特别是出入境受到管制，对瑞晟智能项目的实施及订单的签订影响严重。在之后的两年中，尽管瑞晟智能净利润仍在下滑，但扣非净利润仍保持增长态势。2026上半年，瑞晟智能营业收入较上年增长 50.84%。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/02/20260902959599.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/02/20260902959599.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260902/32357791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IPOS","688215","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664929998","title":"唯捷創芯跌5.24% 2022年上市募資26.7億中信建投保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2664929998","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664929998?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:09","pubTimestamp":1788336542,"startTime":"0","endTime":"0","summary":"中国经济网北京9月2日讯 唯捷创芯 今日收报26.4元，跌幅5.24%。　　唯捷创芯于2022年4月12日在上交所科创板上市，公开发行股票4008.00万股，发行价格为66.60元/股，保荐机构为中信建投证券股份有限公司，保荐代表人为武鑫、沈杰。　　唯捷创芯首次公开发行股票募集资金总额为266,932.80万元，扣除发行费用后，募集资金净额为250,251.13万元。　　唯捷创芯首次公开发行股票的发行费用总额16,681.67万元，其中，保荐及承销费用14,731.30万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260902/32357783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["601066","688153","BK0214","BK0276","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664892996","title":"吉華集團跌7.7% 2017年上市募資17.2億國投證券保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2664892996","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664892996?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:09","pubTimestamp":1788336542,"startTime":"0","endTime":"0","summary":"中国经济网北京9月2日讯 吉华集团 今日收报7.31元，跌幅7.7%。目前该股处于破发状态。　　吉华集团于2017年6月15日在上交所主板上市，发行数量为10,000万股，发行价格为17.20元/股，保荐机构为安信证券股份有限公司，保荐代表人为袁弢、湛瑞锋。　　吉华集团发行费用总额为8,751.76万元，其中承销保荐费7,795.57万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260902/32357784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603980","BK0229","IPOS","161027","BK0192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664892581","title":"*ST卓然連虧1年半 A股共募13億IPO國投證券保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2664892581","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664892581?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:56","pubTimestamp":1788335761,"startTime":"0","endTime":"0","summary":"中国经济网北京9月2日讯 上海卓然工程技术股份有限公司 近日披露2026年半年度报告。报告期内，公司实现营业收入3.45亿元，同比减少64.32%；归属于上市公司股东的净利润-9861.10万元，上年同期为-21.90万元；归属于上市公司股东的扣除非经常性损益的净利润-1.35亿元，上年同期为170.64万元；经营活动产生的现金流量净额1.68亿元，上年同期为-2.59亿元。　　卓然股份于2023年向特定对象发行股票募集资金。　　经计算，卓然股份两次累计募资13.33亿元。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/02/20260902365365.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/02/20260902365365.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260902/32357771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["399300","KCE","03188","161027","159982","688121","BK0251","07233","FRHC","BK1147","IPOS","83130","REDS","82846","02827","BK4127","03130","02846","83188"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":55,"pageCount":53,"totalSize":1094,"code":"91000000","status":"200"}]}}